This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) advanced 7.05% to $349.56 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.90% to 15,226.71 and the Dow Jones Industrial Average rising 0.18% to 35,741.15. Moderna Inc. closed $147.93 below its 52-week high ($497.49), which the company achieved on August 10th.
The stock outperformed some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.59% to $108.50, Amgen Inc. (AMGN) fell 0.77% to $207.63, and AstraZeneca PLC ADR (AZN.LN) fell 0.03% to $61.77. Trading volume (9.6 M) remained 4.0 million below its 50-day average volume of 13.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 25, 2021.
(END) Dow Jones Newswires
October 25, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.